Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?Article Published on 2020-01-012023-07-05 Journal: Drug discoveries & therapeutics [Category] SARS, [키워드] coronavirus Cytokine storm Pneumonia Tocilizumab [DOI] 10.5582/ddt.2020.03006
[First case of COVID-19 treated with tocilizumab in Iceland]Case Reports Published on 2020-01-012023-07-05 Journal: Læknablađiđ [Category] SARS, [키워드] coronavirus COVID-19 Cytokine storm SARS-CoV-2 Tocilizumab [DOI] 10.17992/lbl.2020.05.581 [Article Type] Case Reports
The Combined Use of Tocilizumab and Hemoadsorption in a Patient with SARS-COV-2-19-Associated Pneumonia: A Case ReportCase Reports Published on 2020-01-012023-07-05 Journal: Nephron [Category] SARS, [키워드] C-reactive protein. Cytosorb interleukin 6 SARS-COV-2-19 Tocilizumab [DOI] 10.1159/000509738 PMC 바로가기 [Article Type] Case Reports
Review of current clinical management guidelines for COVID-19 with special reference to IndiaReview Published on 2020-01-012023-07-05 Journal: Drug discoveries & therapeutics [Category] SARS, [키워드] convalescent plasma coronavirus disease 19 Dexamethasone Hydroxychloroquine Remdesivir Tocilizumab [DOI] 10.5582/ddt.2020.03059 [Article Type] Review
Rationale and design of the “Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled” trial (TOCIBRAS)"중등도에서 중증의 COVID-19 환자에 대한 토실리주맙: 공개 라벨 다기관 무작위 통제" 시험(TOCIBRAS)의 근거 및 설계Original Article Published on 2020-01-012022-08-13 Journal: Revista Brasileira de Terapia Intensiva [Category] 임상, [키워드] 7-point ordinal scale adjusted age and sex alleviate Analysis anti-inflammatory therapies Anti-inflammatory therapy applied approved Brazil C reactive protein Clinical outcome clinical outcomes clinical status combating consequence Coronavírus COVID-19 COVID-19 patient COVID-19 patients criteria D-dimer disease severity dissemination enrolment ethical committee Ethics ferritin IMPROVE inflammatory cascade inflammatory mediator Inflammatory response inhibiting institutional review board institutional review boards interleukin-6 International Lactate lactate dehydrogenase limit Local mediator moderate to severe multicentre National Odds ratio Open-label ordinal logistic regression Ordinal Scale outcome patients patients with COVID-19 patients with moderate primary endpoint Pro-inflammatory marker pro-inflammatory markers protocol Randomized Randomized controlled trial rationale required severe COVID-19 severity Standard of care Stratification Study protocol the disease The TOCIBRAS protocol TOCIBRAS Tocilizumab Tocilizumabe Trial trial testing variable [DOI] 10.5935/0103-507X.20200060 PMC 바로가기 [Article Type] Original Article
Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and TisiologySpecial Article Published on 2020-01-012022-10-29 Journal: Revista Brasileira de Terapia Intensiva [Category] COVID-19, [키워드] anticoagulation Bacterial Betacoronavirus Brasil Brazil Chloroquine clinical trials conducted Coronavirus infections/drug therapy Corticosteroids COVID-19 Diretrizes effective Effectiveness Evidence GRADE guideline guidelines hospitalized patients Infecções por coronavirus/tratamento farmacológico Infectious disease Influenza information Interpretation Intervention Medicine methodologist oseltamivir Patient pharmacological pharmacological treatment professional provided Pulmonology Rapid recommendation Result Safe SARS-CoV-2 Society systematic reviews Therapies therapy Tocilizumab treated Treatment use of hydroxychloroquine was performed [DOI] 10.5935/0103-507X.20200039 PMC 바로가기 [Article Type] Special Article
Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapyCase Reports Published on 2019-05-012023-06-01 Journal: Modern rheumatology [Category] 두창, 수두, 홍역, [키워드] IL-6 macrophage activation syndrome Systemic juvenile idiopathic arthritis Tocilizumab varicella [DOI] 10.1080/14397595.2016.1254314 [Article Type] Case Reports
Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature reviewReview Published on 2018-12-142024-09-02 Journal: Pediatric Rheumatology Online Journal [Category] 대상포진, [키워드] Autoimmune disease interleukin-6 Takayasu’s arteritis Tocilizumab [DOI] 10.1186/s12969-018-0296-z PMC 바로가기 [Article Type] Review
Jakinibs for the Treatment of Immunodysregulation in Patients with Gain of Function STAT1 or STAT3 MutationsArticle Published on 2018-11-022024-09-04 Journal: The Journal of Allergy and Clinical Immunology [Category] 대상포진, [키워드] HLH Jakinib ruxolitinib Stat1 STAT3 Tocilizumab Tofacitinib [DOI] 10.1016/j.jaci.2018.07.020 PMC 바로가기 [Article Type] Article
Cellular Stress Response to Varicella-Zoster Virus Infection of Human Skin Includes Highly Elevated Interleukin-6 ExpressionMajor Article Published on 2018-06-222024-09-04 Journal: Open Forum Infectious Diseases [Category] 대상포진, [키워드] autophagy Cytokines Herpes virus Human skin Tocilizumab [DOI] 10.1093/ofid/ofy118 PMC 바로가기 [Article Type] Major Article